SOPHARMA AD (4/2021) Sales revenues for January 2021
Report no 4/2021
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Sopharma AD notifies that for January 2021 the Company recorded a increase in sales of 10% compared to the same month of 2020, incl. 20% increase in domestic sales and 7% increase in export sales.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz